Establish the decision
Understand the product, evidence, markets and time constraints. Agree what the assignment needs to resolve.
OUR APPROACH
Darsh Pharmalink is an independent regulatory consultancy supporting startups, biotech, pharmaceutical companies of all sizes and CRO partners with strategy, technical assessment and submission execution.
EXPERIENCE BEHIND THE WORK
The consultancy draws on more than 15 years of regulatory affairs experience across global and regional roles, supported by an early foundation in process validation and Quality.
That experience spans small molecules, biologics, RNAi therapeutics and combination products, connecting dossier content with manufacturing, development and supply considerations.
Assignments are led by a principal consultant. The scope, responsible individuals and delivery arrangements are agreed at the outset.
HOW AN ASSIGNMENT WORKS
Understand the product, evidence, markets and time constraints. Agree what the assignment needs to resolve.
Set out scope, deliverables, responsibilities and dependencies, with realistic milestones and review points.
Document recommendations, track unresolved issues and communicate decisions clearly to the relevant functions.
WORKING RELATIONSHIPS
Support can focus on a single regulatory question or a defined programme workstream. Collaboration may include Development, Manufacturing, Quality, Supply Chain, CMOs, affiliates and local partners.
Detailed product information is shared under appropriate confidentiality arrangements. Initial enquiries should remain non-confidential.
Explore relevant experience →PRODUCT EXPERTISE
Regulatory support informed by experience across established medicines, innovative therapies and complex product presentations.
CMC submissions, manufacturing transfers and lifecycle strategy, including oral, parenteral and ophthalmic products.
CMC strategy, dossier review and global lifecycle planning, including monoclonal antibodies.
International registration, partner coordination and lifecycle delivery for rare disease therapies.
CMC planning that connects medicinal-product evidence, device-related input and implementation dependencies.
A CLEAR NEXT STEP